Skip to main content
D

DotLab

DotLab develops DotEndo, a non-invasive blood test that utilizes biomarker analysis and biostatistics to identify active endometriosis across all disease stages. This test addresses the significant delay in diagnosis, which can take up to eleven years, by providing timely and actionable insights for patients experiencing unexplained infertility and other symptoms.

Branford, United StatesFounded 201672K+ followers
Updated 20 months ago

Funding

Funding not disclosed

IV
Funding rounds are not available yet.

Founders

Product

Problem

Endometriosis, affecting 1 in 10 women, often faces a significant diagnostic delay, averaging ten years due to the normalization of painful periods and a lack of early detection tools. This delay can lead to disease progression and prolonged suffering for individuals experiencing symptoms like unexplained infertility.

Solution

DotLab offers DotEndo, a non-invasive blood test designed to aid in the diagnosis of active endometriosis across all stages of the disease. DotEndo measures specific biomarkers in the blood, utilizing biostatistics to identify a unique signature indicative of endometriosis, regardless of hormone levels, menstrual cycle phase, or specific symptoms. By providing earlier and more accessible diagnostic information, DotEndo aims to shorten the diagnostic journey, enabling timely intervention and preventing further disease progression. The test addresses the diagnostic gap by offering an advanced, non-invasive, and actionable tool for clinicians.

Target Audience

The primary target audience includes clinicians and patients experiencing unexplained infertility or other symptoms suggestive of endometriosis, as well as women's health specialists seeking earlier and more accurate diagnostic tools.

Features

  • Non-invasive blood test requiring only a standard blood draw.
  • Measures biomarkers in the blood to identify active endometriosis.
  • Employs biostatistics to analyze biomarker data and detect the presence of endometriosis.
  • Identifies endometriosis across all stages of the disease.
  • Results are not affected by hormone levels, menstrual cycle, or specific symptoms.
  • Designed to provide actionable insights for clinicians to speed up the diagnostic process.
This profile is AI-generated and may contain inaccuracies.